Treatment of Ischemic Colitis: First-Line Supportive Management
Ischemic colitis results from reduced blood flow to the colon, causing localised injury. First-line management focuses on prompt supportive care and correction of any identifiable precipitating factors.
Clinical Approach
The initial strategy addresses fluid balance, bowel rest, and infection control simultaneously. Where relevant contributing factors are present — such as elevated blood glucose in patients with diabetes — their correction is an integral part of early care.
Management centres on intravenous fluid resuscitation, bowel rest, and a structured course of intravenous antibiotics — with specific antibiotic selection and the approach to monitoring guided by clinical criteria detailed in the protocol.
Treatment Goals
The primary target is meaningful clinical improvement within 2–3 days. A formal review of antibiotic response at 72 hours is a key decision point in guiding subsequent management.
References
DOI: 10.1136/flgastro-2019-101204
- In addition to intravenous fluid resuscitation and blood glucose control (in patients with diabetes), this generally consists of bowel rest and intravenous antibiotics.
- Bowel rest is achieved through fasting, and in the presence of ileus a nasogastric tube placement.
- Consensus suggests combining anaerobic cover with a third-generation cephalosporin or fluoroquinolone.
- There is also a paucity of data regarding duration of antibiotic treatment, but expert consensus has suggested a pragmatic approach that involves review after 72 hours.
- Where clinical improvement is seen, completion of a 7-day course has been advocated.
- Prophylactic low molecular weight heparin is generally recommended, but there is no established role for formal anticoagulation in the acute setting.
- The duration of bowel rest will depend on severity and clinical response, but in general most improve within 2–3 days (although it is thought to take 1–2 weeks for the colon to heal).